Deb Hart; Head, Investor Relations; Maravai LifeSciences Holdings Inc. William Martin; Chief Executive Officer; Maravai LifeSciences Holdings Inc. Kevin Herde; Chief ...

Phase 1 dataset and late-stage development strategy expected in the third quarter of 2025Eti-cel (UCART20x22) Phase 1 study in relapsed or refractory B-cell non-Hodgkin lymphoma (r/r ...

Gastric cancer, the fifth most common malignancy worldwide and the fifth most common cause of cancer-related death, is ...

Ensoma, a genomic medicines company advancing the future of medicine through one-time, in vivo therapies, today announced U.S ...

An investigative history of the scandal-plagued company shines a light on a health care industry riddled with corruption and ...

Report a crime tip Crime tips can be reported on the Mizzou Safe app or by calling MUPD at 573-882-7201. In-app crime tips ...

Q1 2025 Earnings Call Transcript May 9, 2025 Kymera Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.82, expectations were $-0.92. Justine Koenigsberg: Good morning, and welcome to ...

Q1 2025 Earnings Conference Call May 9, 2025 10:00 AM ETCompany ParticipantsJustine Koenigsberg - Vice President ...

Investigators used DNA evidence surreptitiously collected from trash left at the curb to tie a 43-year-old Winona woman to the 2011 death of Baby Angel. Jennifer Nichole Baechle was arrested ...

The Grand National Tour began April 19 in Minneapolis, and SZA and Lamar performed largely together, interspersed with solo ...

TELO READ THE FULL TELO RESEARCH REPORT Telomir Pharmaceuticals (NASDAQ:TELO) is a preclinical stage biopharmaceutical company developing a product designed to lengthen the DNA’s protective telomere ...

Ginkgo provides an update on its restructuring, including progress towards its expanded $250 million cost savings target Ginkgo and partners awarded $29 million contract ...